Stock Analiz

Gevo, Inc. GEVO

Major Chemicals · IPO 2011 · data as of November 13, 2026

$1.83Market cap $453M
Open the interactive analysis →

Gevo, Inc. (GEVO) is a industrial company listed in the US with a market value of about $453M. In the twelve months to September 30, 2026 it had revenue of $218M and net income of -$182M, a net margin of -83.7%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 96% a year, a 5-year average ROIC of -9%.

About Gevo

Gevo is listed in the US and classified in major chemicals, IPO year 2011. Revenue went from $28M in 2014 to $161M in 2025, growth of about 17.1% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 6% over three years (dilution for shareholders). It spends 3% of revenue on research and development.

Score: 1.6 / 5

Value0/5
Future growth4/5
Track record1/5
Financial health2/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E26.2
P/FCF—
P/S2.1
P/B1.5
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-6.8%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)849.3%
Revenue growth (5 yrs, per year)96.1%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-3507.7%
ROIC (5-yr avg.)-9.1%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$218M$161M$17M$17M$1M$711000$6M$24M$33M$28M$27M
Net income-$182M-$34M-$79M-$66M-$98M-$59M-$40M-$29M-$28M-$25M-$37M
Free cash flow-$31M-$44M-$108M-$108M-$128M-$105M-$26M-$27M-$18M-$23M-$26M
EPS (diluted)$-0.77$-0.14$-0.34$-0.28$-0.44$-0.30$-0.71$-2.35$-5.74$-30.23$-193.52
Net margin-83.7%-21.1%-464.9%-385.0%-8341.0%-8326.7%-725.9%-117.0%-85.1%-89.5%-136.8%
ROIC—-2.5%-12.9%-10.3%-12.0%-7.7%-14.4%-28.4%-17.3%-28.9%-18.1%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 4 analysts is $5.11, 179% above the current price; targets range from $1.20 to $14.00; the consensus rating is “Buy”; expected EPS is $-0.69 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Gevo pay a dividend?

Not currently.

Is Gevo a good stock to buy?

We do not give buy or sell advice. Gevo scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.